|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2002, Vol. 99, No. 4, pp. 1398-1404
NEOPLASIA
BCL10 mutation does not represent an important
pathogenic mechanism in gastric MALT-type lymphoma, and the presence of
the API2-MLT fusion is associated with aberrant nuclear
BCL10 expression
Brigitte Maes,
Anouk Demunter,
Benjamin Peeters, and
Christiane De
Wolf-Peeters
From the Department of Morphology and Molecular
Pathology, Katholieke Universiteit Leuven, Belgium.
Two recurrent translocations have been associated with
mucosa-associated lymphoid tissue (MALT)-type lymphoma,
t(11;18)(q21;q21) and t(1;14)(p22;q32). The first, t(11;18)(q21;q21),
results in the fusion protein API2-MLT (API2-MALT1). Through
t(1;14)(p22;q32), the BCL10 gene is entirely transferred to
the IgH gene, resulting in its overexpression. Wild-type
BCL10 is implicated in apoptosis, and it has been suggested that
mutated forms gain oncogenic activity. The occurrence of genomic
BCL10 mutations in 35 gastric MALT-type lymphomas with or
without t(11;18)(q21;q21) (10 and 25 cases, respectively) was
investigated. DNA extracted from either whole tissue sections or
microdissected clusters of tumor cells was used. Five polymerase chain
reactions amplifying the coding exons were performed and were
followed by direct sequencing of the products. Twenty differences with
the published BCL10 sequence, all single nucleotide
substitutions, were detected in 16 cases. Of these, 12 represented
known polymorphisms, either at codon 8, 213, or 5. Of the remaining 8 substitutions, 2 were silent and 6 resulted in amino acid
substitutions. Mutation analysis results were correlated with the BCL10
expression pattern. Aberrant nuclear BCL10 expression was detected in
14 cases. No association could be demonstrated between the latter and
the presence of BCL10 mutations. In contrast, all 10 cases
carrying t(11;18)(q21;q21) showed nuclear expression, whereas this
staining pattern was absent in 21 of 25 cases without t(11;18)(q21;q21). These results demonstrate that BCL10
mutations are rare in gastric MALT-type lymphoma and are not related to the aberrant nuclear expression of BCL10. In contrast, they indicate that the presence of the API2-MLT fusion protein is associated with
aberrant nuclear BCL10 expression.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H. Zeng, L. Di, G. Fu, Y. Chen, X. Gao, L. Xu, X. Lin, and R. Wen
Phosphorylation of Bcl10 Negatively Regulates T-Cell Receptor-Mediated NF-{kappa}B Activation
Mol. Cell. Biol.,
July 15, 2007;
27(14):
5235 - 5245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M Bacon, M.-Q. Du, and A. Dogan
Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists
J. Clin. Pathol.,
April 1, 2007;
60(4):
361 - 372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lobry, T. Lopez, A. Israel, and R. Weil
Negative feedback loop in T cell activation through I{kappa}B kinase-induced phosphorylation and degradation of Bcl10
PNAS,
January 16, 2007;
104(3):
908 - 913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M-Q Du and J C Atherton
Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.
Gut,
June 1, 2006;
55(6):
886 - 893.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Sagaert, P. de Paepe, L. Libbrecht, V. Vanhentenrijk, G. Verhoef, J. Thomas, I. Wlodarska, and C. De Wolf-Peeters
Forkhead Box Protein P1 Expression in Mucosa-Associated Lymphoid Tissue Lymphomas Predicts Poor Prognosis and Transformation to Diffuse Large B-Cell Lymphoma
J. Clin. Oncol.,
June 1, 2006;
24(16):
2490 - 2497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Baens, S. Fevery, X. Sagaert, H. Noels, S. Hagens, V. Broeckx, A. D. Billiau, C. De Wolf-Peeters, and P. Marynen
Selective Expansion of Marginal Zone B Cells in E{micro}-API2-MALT1 Mice Is Linked to Enhanced I{kappa}B Kinase {gamma} Polyubiquitination.
Cancer Res.,
May 15, 2006;
66(10):
5270 - 5277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nakagawa, Y. Hosokawa, M. Yonezumi, K. Izumiyama, R. Suzuki, S. Tsuzuki, M. Asaka, and M. Seto
MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10
Blood,
December 15, 2005;
106(13):
4210 - 4216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-T. Chen, J.-T. Lin, J. J. Tai, G.-H. Chen, H.-Z. Yeh, S.-S. Yang, H.-P. Wang, S.-H. Kuo, B.-S. Sheu, C.-M. Jan, et al.
Long-Term Results of Anti-Helicobacter pylori Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma
J Natl Cancer Inst,
September 21, 2005;
97(18):
1345 - 1353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-H. Yeh, S.-H. Kuo, L.-T. Chen, T.-L. Mao, S.-L. Doong, M.-S. Wu, H.-C. Hsu, Y.-S. Tzeng, C.-L. Chen, J.-T. Lin, et al.
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)
Blood,
August 1, 2005;
106(3):
1037 - 1041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Minderman, J. M. Conroy, K. L. O'Loughlin, D. McQuaid, P. Quinn, S. Li, L. Pendyala, N. J. Nowak, and M. R. Baer
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells
Mol. Cancer Ther.,
June 1, 2005;
4(6):
885 - 900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Kuo, L.-T. Chen, K.-H. Yeh, M.-S. Wu, H.-C. Hsu, P.-Y. Yeh, T.-L. Mao, C.-L. Chen, S.-L. Doong, J.-T. Lin, et al.
Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts Helicobacter pylori-Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas
J. Clin. Oncol.,
September 1, 2004;
22(17):
3491 - 3497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Pileri, P. L. Zinzani, P. Went, A. Pileri Jr, and M. Bendandi
Indolent lymphoma: the pathologist's viewpoint
Ann. Onc.,
January 1, 2004;
15(1):
12 - 18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Shen, A. C. T. Liang, L. Lu, W. Y. Au, K.-Y. Wong, P.-C. Tin, K.-W. Chan, K.-H. Ko, Y.-W. Chen, S.-L. Beh, et al.
Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma
Blood,
August 15, 2003;
102(4):
1553 - 1554.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ye, H. Liu, A. Attygalle, A. C. Wotherspoon, A. G. Nicholson, F. Charlotte, V. Leblond, P. Speight, J. Goodlad, A. Lavergne-Slove, et al.
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma
Blood,
August 1, 2003;
102(3):
1012 - 1018.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Sanchez-Izquierdo, G. Buchonnet, R. Siebert, R. D. Gascoyne, J. Climent, L. Karran, M. Marin, D. Blesa, D. Horsman, A. Rosenwald, et al.
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
Blood,
June 1, 2003;
101(11):
4539 - 4546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Okabe, H. Inagaki, K. Ohshima, T. Yoshino, C. Li, T. Eimoto, R. Ueda, and S. Nakamura
API2-MALT1 Fusion Defines a Distinctive Clinicopathologic Subtype in Pulmonary Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
Am. J. Pathol.,
April 1, 2003;
162(4):
1113 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood,
February 15, 2003;
101(4):
1220 - 1235.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
